Burning Rock
Burning Rock, Dizal Get Chinese Approval for Lung Cancer CDx
The test, approved by Chinese regulators in early 2022, is designed for the detection of multiple mutation statuses for nine genes.
People in the News at the Chinese University of Hong Kong, Freenome, Burning Rock, Accellix, More
Recently posted executive and academic appointments, promotions, and departures in omics and molecular diagnostics.
In Brief This Week: Burning Rock, iHope Genetic Health, Prenetics, Accenture, Earli, More
News items for the week of Aug. 19, 2024
Burning Rock, Bayer to Develop NGS-Based Companion Diagnostics in China
The companies will jointly develop next-generation sequencing-based companion diagnostic tests for Bayer's precision cancer therapies.
In Brief This Week: Prenetics, US Congress Select Committee, Novigenix, Burning Rock, More
News items for the week of April 1, 2024
Jan 4, 2024
Burning Rock Receives Nasdaq Delisting Warning
Nov 30, 2023
Burning Rock Biotech Q3 Revenues Down 18 Percent
Aug 31, 2023
Burning Rock Biotech Q2 Revenues up 12 Percent
May 30, 2023
Burning Rock Biotech Q1 Revenues up 5 Percent
Nov 16, 2022